52128 Federal Register / Vol. 70, No. 169 / Thursday, September 1, 2005 / Notices 

Prairie, TX, and San Diego, CA. Under 

the terms of the proposed settlement, 

Cosmed will pay a civil penalty of 

$500,000 and fund Supplemental 

Environmental Projects providing 

environmental and public health 

benefits in and around Camden, NJ, 

Lake County, IL, Dallas, TX, and San 

Diego, CA at a cost of $1 million. 

The Department of Justice will receive 

for a period of thirty (30) days from the 

date of this publication comments 

relating to the Consent Decree. 

Comments should be addressed to the 

Assistant Attorney General, 

Environment and Natural Resources 

Division, P.O. Box 7611, U.S. 

Department of Justice, Washington, DC 

20044–7611, and should refer to United 

States v. Cosmed Group, Inc., D.J. Ref. 

90–5–2–1–08115. 

The Consent Decree may be examined 

at the Office of the United States 

Attorney, District of Rhode Island, 50 

Kennedy Plaza, 8th Floor, Providence, 

Rhode Island 02903, and at the United 

States Environmental Protection 

Agency, Region 1 (New England 

Region), One Congress Street, Boston, 

Massachusetts 02114. During the public 

comment period, the Consent Decree 

may also be examined on the following 

Department of Justice Web site, http:// 

www.usdoj.gov/enrd/open.html. A copy 

of the Consent Decree may also be 

obtained by mail from the Consent 

Decree Library, P.O. Box 7611, U.S. 

Department of Justice, Washington, DC 

20044–7611 or by faxing or e-mailing a 

request to Tonia Fleetwood 

(tonia.fleetwood@usdoj.gov), fax no. 

(202) 514–0097, phone confirmation 

number (202) 514–1547. 

In requesting a copy from the Consent 

Decree Library, please enclose a check 

in the amount of $23.75 (25 cents per 

page reproduction cost) payable to the 

U.S. Treasury. 

Ronald G. Gluck, 

Assistant Section Chief, Environmental 

Enforcement Section, Environment and 

Natural Resources Division. 

[FR Doc. 05–17376 Filed 8–31–05; 8:45 am] 

BILLING CODE 4410–15–M 

DEPARTMENT OF JUSTICE 

Notice of Lodging of Consent Decree 

Under Comprehensive Environmental 

Response, Compensation and Liability 

Act 

Under 28 CFR 50.7, notice is hereby 

given that on August 18, 2005, a 

proposed Consent Decree in United 

States v. Novelis Corporation, Civil No. 

05–1046, was lodged with the United 

States District Court for the Northern 

District of New York. 

This action concerns the Pollution 

Abatement Services, Inc. Superfund Site 

in Oswego, New York and the Fulton 

Terminals Sites in Fulton, New York 

(Sites). In this action, the United States 

asserted claims against Novelis 

Corporation under Section 107(a) of the 

Comprehensive Environmental 

Response, Compensation and Liability 

Act (CERCLA), 42 U.S.C. 9607(a), for 

recovery of response costs incurred 

regarding the Sites. The proposed 

consent decree embodies an agreement 

with Novelis to pay $572,000 of EPA’s 

past response costs. The decree provides 

Alcan with a covenant not to sue under 

Section 107(a) of CERCLA. 

The Department of Justice will receive 

for a period of thirty (30) days from the 

date of this publication comments 

relating to the Consent Decree. 

Comments should be addressed to the 

Assistant Attorney General, 

Environment and Natural Resources 

Division, P.O. Box 7611, U.S. 

Department of Justice, Washington, DC 

20044–7611, and should refer to United 

States v. Novelis Corporation, D.J. No. 

90–11–2–2/4. 

The Consent Decree may be examined 

at the Office of the United States 

Attorney for the Northern District of 

New York, 445 Broadway, Albany, NY 

12207, and at the Region II Office of the 

U.S. Environmental Protection Agency, 

Region II Records Center, 290 

Broadway, 17th Floor, New York, NY 

10007–1866. During the public 

comment period, the Consent Decree 

also may be examined on the following 

Department of Justice Web site, http:// 

www.usdoj.gov/enrd/open.html. A copy 

of the Consent Decree also may be 

obtained by mail from the Consent 

Decree Library, P.O. Box 7611, U.S. 

Department of Justice, Washington, DC 

20044–7611 or by faxing or e-mailing a 

request to Tonia Fleetwood 

(tonia.fleetwood@usdoj.gov), fax No. 

(202) 514–0097, phone confirmation 

number (202) 514–1547. In requesting a 

copy from the Consent Decree Library, 

please enclose a check in the amount of 

$3.75 (25 cents per page reproduction 

cost) payable to the U.S. Treasury. 

Ronald G. Gluck, 

Assistant Section Chief, Environmental 

Enforcement Section, Environment and 

Natural Resources Division. 

[FR Doc. 05–17374 Filed 8–31–05; 8:45 am] 

BILLING CODE 4411–15–M 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—World Council of 

Optometry Global Commission on 

Ophthalmic Standards 

Notice is hereby given that, on July 

20, 2005, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), World Council of 

Optometry Global Commission on 

Ophthalmic Standards (‘‘WCO GCOS’’) 

has filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing (1) the name and 

principal place of business of the 

standards development organization 

and (2) the nature and scope of its 

standards development activities. The 

notifications were filed for the purpose 

of invoking the Act’s provisions limiting 

the recovery of antitrust plaintiffs to 

actual damages under specified 

circumstances. 

Pursuant to Section 6(b) of the Act, 

the name and principal place of 

business of the standards development 

organization is: World Council of 

Optometry Global Commission on 

Ophthalmic Standards, Elkins Park, PA. 

The nature and scope of WCO GCOS’s 

standards development activities are: 

the WCO GCOS provides for voluntary, 

impartial ophthalmic product 

evaluation resulting in the issuance of a 

seal of acceptance for those ophthalmic 

products that meet published standards 

specifications developed by the WCO 

GCOS, including biological, laboratory, 

and/or clinical evaluations, or the 

issuance of a seal of certification for 

those ophthalmic products that meet 

standards already approved by accepted 

standards organizations and which are 

designated for use by the WCO GCOS. 

The WCO GCOS selects the categories of 

products to be evaluated and develops 

evaluation specifications/standards for 

those ophthalmic products using the 

American National Standard Institute’s 

Third Party Certification Program 

Principles (ANSI Z34. 1–1993). Product 

categories for which the WCO GCOS 

currently has approved standards are: 

ultraviolet absorbers and blockers. 

Additional categories are always under 

review. The WCO GCOS abides by a 

strict Code of Conduct for reviewing any 

applications for seals of acceptance or 

certification and for developing